Skip to main content
. Author manuscript; available in PMC: 2011 Dec 30.
Published in final edited form as: N Engl J Med. 2011 Jun 30;364(26):2496–2506. doi: 10.1056/NEJMoa1013343

Table 2.

Hazard Ratios for Death in a Multivariable Model.*

Risk Factor Hazard Ratio (95% CI) P Value
Age ≥55 yr vs. <55 yr 1.81 (1.20–2.73) 0.004
IPSS risk group
 Intermediate-1 vs. low 2.29 (1.69–3.11) <0.001
 Intermediate-2 vs. low 3.45 (2.42–4.91) <0.001
 High vs. low 5.85 (3.63–9.40) <0.001
Mutational status
TP53 mutation present vs. absent 2.48 (1.60–3.84) <0.001
EZH2 mutation present vs. absent 2.13 (1.36–3.33) <0.001
ETV6 mutation present vs. absent 2.04 (1.08–3.86) 0.03
RUNX1 mutation present vs. absent 1.47 (1.01–2.15) 0.047
ASXL1 mutation present vs. absent 1.38 (1.00–1.89) 0.049
*

The model was generated from a stepwise Cox regression model that included the International Prognostic Scoring System (IPSS) risk category (based on the percentage of blasts in bone marrow, the karyotype, and the number of cytopenias [see Table 2 in the Supplementary Appendix]), age, sex, and mutation status for genes that were mutated in 1% or more of the 428 samples for which the IPSS classification was recalculated. Age was included in the analysis as a categorical variable on the basis of a best-split algorithm showing a significant difference in overall survival between patients less than 55 years of age and those 55 years of age or older (see Table 8 in the Supplementary Appendix).